Terms: = Uterine cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
1632 results:
1. The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
Voidăzan TS; Budianu MA; Cotoi OS; Turdean SG
Rom J Morphol Embryol; 2024; 65(1):99-105. PubMed ID: 38527989
[TBL] [Abstract] [Full Text] [Related]
2. Correlation between p16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
Srisuttayasathien M; Kantathavorn N; Luasiripanthu T; Petchjorm S; Samrarn J; Ittiamornlert P; Krisorakun W; Vanichtantikul A; Wetcho T; Saeloo S
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):192-198. PubMed ID: 38485314
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between high-risk HPV infection and p16/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort.
Shalaby NA; Tudorescu-Morjan C; Manole CG; Iacata AA; Popovici ML; Grecu LI; Curici A
J Med Virol; 2024 Mar; 96(3):e29524. PubMed ID: 38483062
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatics identification of characteristic genes of cervical cancer via an artificial neural network.
Liu L; Huang L; Deng L; Li F; Vannucci J; Tang S; Wang Y
Chin Clin Oncol; 2024 Feb; 13(1):4. PubMed ID: 38453655
[TBL] [Abstract] [Full Text] [Related]
6. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
Clarke MA; Wentzensen N; Perkins RB; Garcia F; Arrindell D; Chelmow D; Cheung LC; Darragh TM; Egemen D; Guido R; Huh W; Locke A; Lorey TS; Nayar R; Risley C; Saslow D; Smith RA; Unger ER; Massad LS;
J Low Genit Tract Dis; 2024 Apr; 28(2):124-130. PubMed ID: 38446575
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
8. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
[TBL] [Abstract] [Full Text] [Related]
9. Assessment and clinicopathological correlation of p16 expression in cervical squamous cell carcinoma of Indian population: Diagnostic implications.
Paul A; Dutta P; Basu K
J Cancer Res Ther; 2023 Oct; 19(7):2012-2017. PubMed ID: 38376311
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical markers Ki67 and p16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract] [Full Text] [Related]
12. Autophagy-related risk signature based on CDNK2A to facilitate survival prediction of patients with endometrial cancer.
Yue C; Lin B; Sun X; Xu X; Zhou C; Fan J
J Gene Med; 2024 Jan; 26(1):e3648. PubMed ID: 38282156
[TBL] [Abstract] [Full Text] [Related]
13. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
14. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
15. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
16. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
Barquín García A; Palacios-Zambrano S; Lozano Alarcón F; Paumard-Hernández B; Quiralte Pulido M; Navarro P; Rodríguez L; Salas Villar I; García-Donas J
J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237079. PubMed ID: 38150820
[TBL] [Abstract] [Full Text] [Related]
17. Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.
Makk E; Bohonyi N; Oszter A; Éles K; Tornóczky T; Tóth A; Kálmán E; Kovács K
Pathol Oncol Res; 2023; 29():1611547. PubMed ID: 38146588
[No Abstract] [Full Text] [Related]
18. Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker.
Shafique M; Shoaib I; Aslam B; Khalid R; Tanvir I; Rasool MH; Shah TA; Almaary KS; Bourhia M; Qamar MU
Arch Microbiol; 2023 Dec; 206(1):17. PubMed ID: 38085340
[TBL] [Abstract] [Full Text] [Related]
19. The use of colposcopy for triage in HPV-positive women aged 65 years and older.
Kuenkel E; Jaeger A; Bohlmann I; Bergauer F; Kuehler-Obbarius C; Prieske K; Maass-Poppenhusen K; Schmalfeldt B; Woelber L
Arch Gynecol Obstet; 2024 Apr; 309(4):1561-1567. PubMed ID: 38081959
[TBL] [Abstract] [Full Text] [Related]
20. Risk Factors for Persistence or Recurrence of High-Grade Cervical Squamous Intraepithelial Lesions.
Bittencourt DD; Zanine RM; Sebastião APM; Ribas CM
Rev Col Bras Cir; 2023; 50():e20233537. PubMed ID: 38055549
[TBL] [Abstract] [Full Text] [Related]
[Next]